3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
55
Myelodysplastic Syndromes
32
Leukemia
18
Leukemia, Myelomonocytic, Chronic
11
Congenital Abnormalities
5
Recurrence
4
Neoplasms
4
Melanoma
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Leukemia, Megakaryoblastic, Acute
3
Leukemia, Erythroblastic, Acute
3
Carcinoma, Non-Small-Cell Lung
3
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Anemia, Refractory
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Thrombocytopenia
1
Thrombocythemia, Essential
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Primary Myelofibrosis
1
Interventions
ruxolitinib
4
ponatinib
4
nilotinib
4
Imatinib Mesylate
4
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
sonidegib
1
simtuzumab
1
pembrolizumab
1
ibrutinib
1
bosutinib
1
Zoledronic Acid
1
Denosumab
1
CPI-0610
1
BID protein, human
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Bone Marrow Diseases
×
Decitabine
×
Clear all
No trials found.